Annals of Clinical and Translational Neurology (May 2023)

Attack phenotypes and disease course in pediatric MOGAD

  • Jonathan D. Santoro,
  • Timothy Beukelman,
  • Cheryl Hemingway,
  • Suvi R. K. Hokkanen,
  • Frank Tennigkeit,
  • Tanuja Chitnis

DOI
https://doi.org/10.1002/acn3.51759
Journal volume & issue
Vol. 10, no. 5
pp. 672 – 685

Abstract

Read online

Abstract Myelin oligodendrocyte glycoprotein antibody‐associated disease (MOGAD) is an autoimmune demyelinating condition that affects children differently than adults. We performed a literature review to assess the presentation and clinical course of pediatric MOGAD. The most common initial phenotype is acute disseminated encephalomyelitis, especially among children younger than five years, followed by optic neuritis (ON) and/or transverse myelitis. Approximately one‐quarter of children with MOGAD have at least one relapse that typically occurs within three years of disease onset and often includes ON, even if ON was not present at onset. Clinical risk factors for a relapsing course have not been elucidated.